Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MH004 Ointment in Non-segmental Vitiligo
NCT07181187Phase 2Completed
- Sponsor
- Minghui Pharmaceutical, Inc.
- Start
- Mar 2024
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tofacitinib etocomil in Vitiligo, sponsored by Minghui Pharmaceutical, Inc.. Started Mar 2024; status: completed.
02
Drugs
tofacitinib etocomil
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07181187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07181187.